Patents
Patents for C07J 3 - Normal steroids containing carbon, hydrogen, halogen, or oxygen, substituted in position 17 beta by one carbon atom (1,033)
06/2010
06/17/2010US20100152148 Novel compounds
06/10/2010US20100143830 Sulfonium salt, acid generator, resist composition, photomask blank, and patterning process
05/2010
05/25/2010US7723532 Pharmaceutical compositions 3
05/18/2010US7718793 Reacting 17-hydroxy-9 beta ,11 beta -epoxy-16- beta -methyl-pregna-1,4-diene-3,20-dione 21-acetate compound with a stereoselective fluorinating agent to stereoselectively form a 21-ester, 17-hydroxy 6 alpha -fluorinated compound
05/12/2010EP1644397B1 Specific glucocorticosteroid compound having anti- inflammatory activity
05/04/2010CA2462456C Androstane 17-beta-carboxamides as androgen receptor modulators
04/2010
04/22/2010US20100099654 Fatty acid esters of glucocorticoids as anti-inflammatory and anti-cancer agents
04/06/2010US7691836 Progesterone receptor modulators
03/2010
03/04/2010US20100056488 Corticosteroid conjugates and uses thereof
03/03/2010CN101659688A Method for recrystallizing and refining fluticasone propionate
03/03/2010CN101659687A Novel anti-inflammatory androstane compound
02/2010
02/24/2010CN101654470A Intermediate used as anti-inflammatory androstane derivative compositions and uses thereof
02/18/2010US20100041906 Method for the precipitation of organic compounds
12/2009
12/29/2009US7638508 Glucocorticosteroid compound having anti-inflammatory activity
12/08/2009US7629335 comprising a drug compound 6 alpha ,9 alpha -Difluoro-17 alpha -[(2-furanylcarbony)oxy]-11 beta -hydroxy-16 alpha -methyl-3-oxo-androsta-1,4-diene-17 beta -carbothioic acid S-fluoromethyl ester; dry powder inhaler; with predictable pharmacokinetic and pharmacodynamic behaviour
12/03/2009WO2009108388A3 Enzymatic production or chemical synthesis and uses for 5,7-dienes and uvb conversion products thereof
11/2009
11/25/2009CN101585862A Novel steroids
11/18/2009CN100560598C Synthesis method of fluoticarson propionate
11/05/2009US20090275767 Process for synthesis of androstane 17-beta carbothioic acid and relative compounds thereof
10/2009
10/14/2009CN100549022C Method for preparing fluticasone propionate
09/2009
09/22/2009US7592329 containing an anti-inflammatory and anti-allergic compound of the androstane series
09/03/2009WO2009108388A2 Enzymatic production or chemical synthesis and uses for 5,7-dienes and uvb conversion products thereof
08/2009
08/27/2009US20090215737 Pharmaceutical Compositions - 2
08/25/2009US7579335 e.g. Cyanomethyl (6 alpha ,11 beta ,16 alpha ,17 alpha )-17-({[(1,1-dimethylethyl)oxy]carbonyl}oxy)-6,9-difluoro-11-hydroxy-16-methyl-3-oxoandrosta-1,4-diene-17-carboxylate; glucocorticoid receptor agonists of the androstane series; with other beta 2-adrenoreceptor agonist; asthma, rhinitis, eczema
07/2009
07/23/2009US20090187032 INDUSTRIAL PROCESS FOR THE SYNTHESIS OF 17alpha-ACETOXY-11beta-[4-(N,N-DIMETHYL-AMINO)-PHENYL]-19-NORPREGNA-4,9-DIENE-3,20-DIONE AND NEW INTERMEDIATES OF THE PROCESS
07/08/2009CN101479291A Amino derivatives of B-homoandrostanes and B-heteroandrostanes
06/2009
06/25/2009US20090163458 Compositions and methods for treating Parkinson's disease and related disorders
06/18/2009US20090156567 Novel anti-inflammatory androstane derivative
06/10/2009EP2067784A2 17.beta.-carbothioate 17.alpha.-arylcarbonyloxyloxy androstane derivates as anti-flammatory agents
06/10/2009CN100497367C Synthesizing process of fluorine propionate ticasone
06/02/2009US7541350 Formulation containing anti-inflammatory androstane derivative
05/2009
05/12/2009US7531528 mixture of aqueous carrier liquid containing dissolved glucocorticoid and 3-oxoandrostane carbothioic coompound
05/12/2009CA2315829C Angiostatic agents and compositions for controlling ocular hypertension
05/07/2009US20090118495 Process for the Preparation of 6-alpha,9-alpha-difluoro-17-alpha-((2-furanylcarbonyl)oxy)-11-beta-hydroxy-16-alpha-methyl-3-oxo-androsta-1,4-diene-17-beta- -carbothioic acid S-fluoromethyl
04/2009
04/28/2009US7524970 Compounds
04/28/2009US7524835 Tetrol steroids and esters
04/28/2009US7524834 Antiinflammatory and antiallergic glucocorticosteroid, sterile glucocorticosteroids
03/2009
03/11/2009EP2032593A1 Amino derivatives of b-homoandrostanes and b-heteroandrostanes
03/11/2009EP1212618B1 Effect of steroids on nmda receptors depends on subunit composition
03/11/2009CN101384610A Novel 11 beta - hydroxyandrosta-4-ene-3-ones
03/05/2009US20090062230 Novel cationic 17 alpha-substituted-estradiol derivatives useful as anti-cancer agent
03/03/2009US7498321 17β-carbothioate 17α-arylcarbonyloxyloxy androstane derivative as anti-inflammatory agents
02/2009
02/26/2009US20090054388 Novel 11 beta-hydroxyandrosta-4-ene-3-ones
02/26/2009US20090054387 Method for preparing 4-[17beta-methoxy-17alpha-methoxymethyl-3-oxestra-4,9-dien-11beta-yl]benzaldehyde (E)-oxime (asoprisnil)
02/25/2009CN101372499A Novel medicament having antiinflammatory activity
02/19/2009US20090048218 17Beta-CYANO-18A-HOMO-19-NOR-ANDROST-4-ENE DERIVATIVE, ITS USE AND MEDICAMENTS COMPRISING THE DERIVATIVE
02/19/2009US20090048217 17Beta-CYANO-19-NOR-ANDROST-4-ENE DERIVATIVE, ITS USE AND MEDICAMENTS COMPRISING THE DERIVATIVE
02/12/2009US20090042844 17alpha-substituted steroids as systemic antiandrogens and selective androgen receptor modulators
01/2009
01/28/2009CN101353367A Refining method of fluticasone propionate
01/22/2009US20090023695 METHOD OF MAKING AND USING 7alpha,11beta-DIMETHYL-17beta-HYDROXYESTR-4-EN-3-ONE 17-UNDECANOATE
01/06/2009CA2412541C 9.alpha.-chloro-6.alpha.-fluoro-17.alpha.-hydroxy-16-methyl-17-.beta.-methoxycarbonyl-androst-1,4-dienes esterified in position 17.alpha. by a cyclic acyl group
12/2008
12/24/2008EP2004667A2 Novel 11 beta - hydroxyandrosta-4-ene-3-ones
12/03/2008EP1305330B1 17.beta.-carbothioate 17.alpha.-arylcarbonyloxyloxy androstane derivatives as anti-inflammatory agents
11/2008
11/06/2008WO2008133387A1 New acyclic triterpenoids compound, and pharmaceutical composition comprising alpinia katsumadai extract or acyclic triterpenoids compounds isolated from the same
10/2008
10/29/2008CN100429221C Synthesis method of cortin
10/09/2008WO2007099548A3 Novel 11 beta - hydroxyandrosta-4-ene-3-ones
10/09/2008US20080249077 glucocorticoid receptor agonists; to treat inflammatory and allergic conditions; Fluoromethyl(6 alpha ,11 beta ,16 alpha ,17 alpha )-17-({[(1,1-dimethylethyl)oxy]carbonyl}oxy)-6,9-difluoro-11-hydroxy-16-methyl-3-oxoandrosta-1,4-diene-17-carboxylate
09/2008
09/23/2008US7427610 e.g. 17 beta -Difluoromethyl-2-methoxy-estra-1,3,5(10)-trien-3-yl sulfamate; tubulin polymerization inhibitor; breast, prostate, colon, non-small-cell-lung cancer and primary dermal microvascular endothelial cell proliferation
08/2008
08/20/2008EP1957512A1 17.beta.-fluoromethoxycarbonyl-androst-4-en-3-one compounds with a 17.alpha.-carbonate substituent
08/20/2008EP1836215B1 Androstane 17-alpha-carbonate for use in the treatment of inflammatory and allergic conditions
07/2008
07/31/2008US20080182831 e.g. Cyanomethyl (6 alpha ,11 beta ,16 alpha ,17 alpha )-17-({[(1,1-dimethylethyl)oxy]carbonyl}oxy)-6,9-difluoro-11-hydroxy-16-methyl-3-oxoandrosta-1,4-diene-17-carboxylate; glucocorticoid receptor agonists of the androstane series; with other beta 2-adrenoreceptor agonist; asthma, rhinitis, eczema
07/24/2008US20080176824 Pharmaceutical Compositions 3
07/22/2008US7402577 Androstane 17-beta-carboxamides as androgen receptor modulators
07/08/2008US7396827 Pharmaceutical compositions and treatment methods
07/02/2008CN100398552C Method for removing carbonylazathia acetal protection group
06/2008
06/18/2008EP1301526B1 Oxidation process for preparing the intermediate 6.alpha.,9.alpha.-difluoro-11.beta.,17.alpha.-dihydroxy-16.alpha.-methyl-androst-1,4-dien-3-one 17.beta.-carboxylic acid
06/10/2008US7384973 Materials and methods for treating hypercholesterolemia
06/10/2008CA2259981C 6,7-oxygenated steroids and uses related thereto
06/05/2008US20080132561 Materials and Methods for Treating Hypercholesterolemia
06/04/2008EP1927359A2 2-Methoxyestradiol for the treatment of inflammatory disorders
05/2008
05/13/2008US7371741 Angiogenesis inhibitor
05/13/2008CA2310222C New composition of matter
04/2008
04/17/2008US20080090792 Selective glucocorticoid receptor agonists
03/2008
03/20/2008US20080070880 Specific glucocorticosteroid compound having anti-inflammatory activity
02/2008
02/21/2008US20080045490 Pharmaceutical Compositions
02/20/2008CN101125875A Method for preparing fluticasone propionate
01/2008
01/29/2008CA2436540C Pharmaceutical compositions based on anticholinergics and corticosteroids
01/29/2008CA2093808C Methods, compositions, and compounds for allosteric modulation of the gaba receptor by members of the androstane and pregnane series
01/24/2008US20080021231 Novel compounds
01/17/2008US20080015360 2,3-Dimethyl-1-[(2,2,3,3-tetramethylcyclopropyl)carbonyl]-1H-imidazol-3-ium chloride; intermediate for preparing androstane-type glucocorticoid receptor agonists
01/15/2008CA2123405C Angiostatic steroids
01/08/2008CA2450661C Preparation of flumethasone and its 17-carboxyl androsten analogue
12/2007
12/27/2007WO2007147713A1 Amino derivatives of b-homoandrostanes and b-heteroandrostanes
12/27/2007US20070298456 Microbiological process for the production of 7-substitued 11-hydroxy steroids, 7,17-substituted 11-halogen steroids, and uses thereof
12/27/2007CA2654354A1 Amino derivatives of b-homoandrostanes and b-heteroandrostanes
12/13/2007US20070287846 Process for the Esterification of a Carbothioic Acid
11/2007
11/22/2007US20070270584 Process for the Preparation of Steroidal Carbothioic Acid Derivatives and Intermediates
11/21/2007CN101076538A Steroids for cancer treatment
11/06/2007US7291610 Estrogenic compounds as anti-mitotic agents
11/06/2007US7291609 Specific glucocorticosteroid compound having anti-inflammatory activity
11/06/2007US7291608 Anti-inflammatory 17.β.-carbothioate ester derivatives of androstane with a cyclic ester group in position 17.α
10/2007
10/31/2007CN100345862C Steroid compounds preparation method
10/30/2007US7288536 For therapy of skin diseases such as eczema, psoriasis, allergic dermatitis neurodermatitis, pruritis and hypersensitivity reactions; inflammatory conditions of the nose, throat or lungs such as asthma (including allergen-induced asthmatic reactions), rhinitis (including hayfever), nasal polyps
10/23/2007CA2478971C Androstenones
10/23/2007CA2449679C Androstenones
10/18/2007DE102006018869A1 17alpha-substituierte 4-(3-Oxoestra-4,9-dien-11beta-yl)-benzoesäure, deren Derivate und Verfahren zu ihrer Herstellung 17alpha-substituted 4- (3-oxoestra-4,9-dien-11beta-yl) benzoic acid, their derivatives and process for their preparation
10/10/2007EP1841780A2 Androstane 17-alpha-carbonate derivatives for use in the treatment of allergic and inflammatory conditions
09/2007
09/27/2007US20070225256 Compound
09/26/2007EP1836215A1 Androstane 17-alpha-carbonate for use in the treatment of inflammatory and allergic conditions
09/26/2007CN100339486C Microbiological method for the production of 7 alpha-substituted 11 alpha-hydroxysteroids
1 2 3 4 5 6 7 8 9 10 11